Vicarious Surgical Inc (NYSE:RBOT) Short Interest Update

Vicarious Surgical Inc (NYSE:RBOTGet Free Report) was the recipient of a significant decline in short interest in June. As of June 15th, there was short interest totalling 179,600 shares, a decline of 96.3% from the May 31st total of 4,840,000 shares. Based on an average daily trading volume, of 19,900 shares, the short-interest ratio is presently 9.0 days.

Institutional Investors Weigh In On Vicarious Surgical

Institutional investors have recently added to or reduced their stakes in the stock. Element Capital Management LLC bought a new position in shares of Vicarious Surgical during the 3rd quarter worth approximately $585,000. Regal Partners Ltd acquired a new stake in Vicarious Surgical in the 3rd quarter valued at $390,000. Seven Grand Managers LLC bought a new stake in Vicarious Surgical during the 3rd quarter worth about $295,000. Hudson Bay Capital Management LP bought a new stake in Vicarious Surgical during the 3rd quarter worth about $207,000. Finally, DDD Partners LLC boosted its stake in shares of Vicarious Surgical by 4.2% during the 4th quarter. DDD Partners LLC now owns 6,623,192 shares of the company’s stock worth $2,429,000 after buying an additional 269,523 shares during the last quarter. 47.27% of the stock is owned by institutional investors.

Vicarious Surgical Stock Performance

RBOT traded up $0.32 during trading on Thursday, reaching $6.99. 36,097 shares of the company’s stock were exchanged, compared to its average volume of 21,274. The company’s fifty day moving average price is $9.10 and its 200-day moving average price is $10.56. The firm has a market capitalization of $41.03 million, a PE ratio of -0.60 and a beta of 1.21. Vicarious Surgical has a fifty-two week low of $6.00 and a fifty-two week high of $62.10.

Vicarious Surgical (NYSE:RBOTGet Free Report) last issued its earnings results on Monday, April 29th. The company reported ($2.70) EPS for the quarter, beating the consensus estimate of ($3.00) by $0.30. Research analysts forecast that Vicarious Surgical will post -10.91 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Piper Sandler decreased their price target on Vicarious Surgical from $45.00 to $30.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 5th.

Read Our Latest Stock Report on Vicarious Surgical

About Vicarious Surgical

(Get Free Report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Further Reading

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with's FREE daily email newsletter.